# Podocyte Retinoids

> **NCT00098020** · PHASE2 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 12 (actual)

## Conditions studied

- Collapsing Glomerulopathy
- Glomerulosclerosis, Focal Segmental

## Interventions

- **DRUG:** Isotretinoin

## Key facts

- **NCT ID:** NCT00098020
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11-26
- **Primary completion:** 2016-06-27
- **Final completion:** 2016-06-27
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00098020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00098020, "Podocyte Retinoids". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00098020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*